20(27.78%) male patients, 4(18.67%) female patients had LVH in group I and group II respectively. Ischemic heart disease was found 11(19.64%) and 29(65.9%) patients, arrhythmias were 2(3.57%) and 6(13.63%) patients in group I and group II respectively. Heart failure was found 10(22.72%) patients in group II and none in group I. In group I, 4(7.1%) patients had systolic dysfunction (EF <55% and FS <25%), 4(7.1%) patients had valvular calcification. In group II, 12(27.3%) patients had systolic dysfunction, 28(63.6%) patients had valvular calcification. 36.4% patients had pericardial effusion in group II and not found in group I. These difference between group I and group II were statistically significant (p<0.05). 32(57.1%) patients had diastolic dysfunction (E/A <0.8 & >2) in group I and 24(54.5%) in group II. Thus we may conclude ischemic heart disease, heart failure, arrhythmia, pericardial effusion, valvular calcification, left ventricular hypertrophy and systolic dysfunction are significantly higher in severe CKD with type 4 cardiorenal syndrome.
So proper blood pressure management as well as periodic cardiovascular monitoring with ECG and Doppler Echocardiogram are easy way to trace on-coming cardiac events in patients with CKD.
